Carolyn Sweeney

Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial.

S. Paukner, G. Moran, Anita F. Das, 2019, JAMA.

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

T. File, S. Paukner, G. Talbot, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Health Care Providers’ Knowledge, Practices, and Barriers to Hepatitis Vaccination Guidelines

P. Buck, O. Herrera-Restrepo, Kimberly Davis, 2022, The Journal for Nurse Practitioners.